Results 251 to 260 of about 355,535 (359)

[Anti-arrhythmia agents in heart failure].

Kardiologiia, 1992
I Brakhmann, K Shmitt, T. Baier, B Valdeker, T Khilbel, ShvaĭtserM, Kiubler   +6 more
openalex   +2 more sources

[Anti-arrhythmia agents: results and outlook].

Eksperimental'naia i klinicheskaia farmakologiia, 1995
Kaverina Nv
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

[New anti-arrhythmia agents].

Zeitschrift fur Kardiologie, 1993
Use of class-I antiarrhythmic agents (encainide, flecainide or moricizine) to suppress asymptomatic ventricular premature depolarizations does not decrease, but rather increases mortality from cardiac events after myocardial infarction. These patients should not be treated with antiarrhythmic drugs until improved survival is shown in a controlled ...
P, Honerjäger, G, Schmidt
openaire   +1 more source

[Combined action of anti-arrhythmia agents].

Biulleten' eksperimental'noi biologii i meditsiny, 1991
A significant potentiation of antiarrhythmic effect was observed in 121 dogs with arrhythmias 24 and 48 hours after the coronary artery ligation when the following drugs were combined: N-propylajmaline bromide (1A class) and trimecaine (1B class), quinidine (1A class) and trimecaine, N-propylajmaline bromide and anaprilin (2 class). The potentiation is
E I Gendenshteĭn, Ia V Kostin, В. П. Балашов, В. Э. Олейников   +3 more
openalex   +3 more sources

[Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?].

Deutsche Medizinische Wochenschrift, 2008
G. Steinbeck, R. Doliwa, P. Bach
semanticscholar   +1 more source

[Hemodynamic aspects in therapy with anti-arrhythmia agents].

Deutsche Medizinische Wochenschrift, 2008
B. Lüderitz
semanticscholar   +1 more source

[The cardiotoxic properties of anti-arrhythmia agents].

Eksperimental'naia i klinicheskaia farmakologiia, 1997
Experiments were conducted on cats to study the cardiotoxic and arrhythmogenic properties of some antiarrhythmic agents in continuous intravenous infusion in doses multiple of the dose which causes an antiarrhythmic effect on an acontic model of arrhythmia in rats in 50% of cases.
A A, Spasov, N A, Gurova
openaire   +1 more source

[Hemodynamic effects of class-I and class-III anti-arrhythmia agents].

Deutsche Medizinische Wochenschrift, 2008
G. Schmidt, P. Honerjäger, T. Niesel
semanticscholar   +1 more source

Advances in applications of anti-arrhythmia agents and safety evaluation

, 2012
Xiaohua Zhuang, Tao Chen, Tao Xu, De-ning Liao   +3 more
semanticscholar   +1 more source

[Arrhythmogenic effects of anti-arrhythmia agents].

Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1987
Arrhythmogenic effects appear in 5-22% of all patients. On the basis of a literary investigation on 11,547 patients with 1,114 proarrhythmic effects and of 21 own observations mechanisms, risks and diagnostics of this dangerous side effect are demonstrated.
D, Pfeiffer, K J, Rostock, K, Rathgen, A, Schirdewan, H J, Kleiner   +4 more
openaire   +1 more source